EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewé, J Bijlsma… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …
被引用次数：3093 相关文章

[引用][C] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewe, J Bijlsma… - Annals of the …, 2017 - espace.library.uq.edu.au
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewé… - Annals of the …, 2017 - researchinformation.amsterdamumc …
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …
[PDF] core.ac.uk

[PDF][PDF] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

C Buckley - core.ac.uk
Recent insights in RA necessitated updating the EULAR RA management
recommendations. A large international Task Force based decisions on evidence from 3 …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewe… - Annals of the …, 2017 - scholarlypublications …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and
biological disease-modifying antirheumatic drugs: 2016 update | Scholarly Publications Skip to …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewé, H Bijlsma… - Annals of the …, 2017 - repub.eur.nl
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …

[引用][C] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewe, J Bijlsma, G Burmester… - 2017 - repository.ubn.ru.nl
EULAR recommendations for the management of rheumatoid arthritis with synthetic and
biological disease-modifying antirheumatic drugs: 2016 update Toggle navigation Radboud …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewé, J Bijlsma… - Annals of the …, 2017 - keio.elsevierpure.com
抄録 Recent insights in rheumatoid arthritis (RA) necessitated updating the European
League Against Rheumatism (EULAR) RA management recommendations. A large …
[PDF] birmingham.ac.uk

[PDF][PDF] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

C Buckley - research.birmingham.ac.uk
Recent insights in RA necessitated updating the EULAR RA management
recommendations. A large international Task Force based decisions on evidence from 3 …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 Update

JS Smolen, R Landewe… - Annals of the …, 2017 - research.manchester.ac.uk
Recent insights in RA necessitated updating the EULAR RA management
recommendations. A large international Task Force based decisions on evidence from 3 …